BELLEVUE GROUP AG – Supernus Pharmaceuticals, Inc. Transaction History
BELLEVUE GROUP AG portfolio value:
$4.03M
portfolio value
BELLEVUE GROUP AG quarter portfolio value change:
+17.05%
quarter
Supernus Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +44.75% | 36.87K shares | 1.65M | $33.85 | 119.27K |
| Q2 2022 | share | Increase | +39.66% | 23.4K shares | 476K | $28.92 | 82.4K |
| Q1 2022 | share | Increase | 0.00% | 59K shares | 1.90M | $32.32 | 59K |
| Q2 2020 | share | Decrease | -100.00% | -552.8K shares | -9.94M | $23.75 | 0 |
| Q1 2020 | share | Decrease | -3.96% | -22.8K shares | -3.70M | $17.99 | 552.8K |
| Q4 2019 | share | Increase | +38.17% | 159K shares | 2.20M | $23.72 | 575.6K |
| Q3 2019 | share | Decrease | -10.79% | -50.4K shares | -4.00M | $27.48 | 416.6K |
| Q2 2019 | share | Increase | +60.48% | 176K shares | 5.25M | $33.09 | 467K |
| Q1 2019 | share | Decrease | -15.68% | -54.1K shares | -1.26M | $35.04 | 291K |
| Q4 2018 | share | Decrease | -10.71% | -41.4K shares | -7.99M | $33.22 | 345.1K |
| Q3 2018 | share | Increase | +18.34% | 59.9K shares | -87K | $50.35 | 386.5K |
| Q2 2018 | share | Increase | +13.09% | 37.8K shares | 6.32M | $59.85 | 326.6K |
| Q1 2018 | share | Increase | +20.13% | 48.4K shares | 3.64M | $45.8 | 288.8K |
| Q4 2017 | share | Increase | 0.00% | 240.4K shares | 9.58M | $39.85 | 240.4K |
| Q3 2016 | share | Decrease | -100.00% | -164K shares | -3.34M | $24.73 | 0 |
| Q2 2016 | share | Decrease | -62.81% | -277K shares | -3.38M | $20.37 | 164K |
| Q1 2016 | share | Increase | 0.00% | 441K shares | 6.72M | $15.25 | 441K |